Keywords
Cardiology
Epidemiology
Heart failure
Metabolic syndrome
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify the prevalence of metabolic syndrome among heart failure patients under outpatient follow-up at a referral unit in the state of Pernambuco, Brazil. Methods: A cross-sectional, exploratory, and observational study with a non-probabilistic convenience sample was conducted in Recife, Pernambuco, from April to June 2018. Data collection included the application of a specific instrument as well as blood sample collection and analysis. The diagnosis of metabolic syndrome followed the Brazilian criteria established by the Brazilian Society of Endocrinology and Metabolism and the National Cholesterol Education Program. Results: A total of 110 patients were evaluated, 65.5% (n: 72) of whom were male, with a mean age of 59±13 years. The frequency of metabolic syndrome was 29% (n: 32), showing significant correlations with age (p<0.020), sex (p<0.018), hypertension (p<0.035), and diabetes mellitus (p<0.001). Conclusion: The prevalence of metabolic syndrome was significant and associated with factors such as age, sex, hypertension, and diabetes mellitus. The findings highlight the need for screening and integrated management. Specific strategies could improve the prognosis for these patients.
References
ALBUQUERQUE DC, et al. I Registro Brasileiro de Insuficiência Cardíaca – Aspectos Clínicos, Qualidade Assistencial e Desfechos Hospitalares. Arq Bras Cardiol. 2015; 104(6): 433-42.
ALMEIDA GAS, et al. Perfil de saúde de pacientes acometidos por insuficiência cardíaca. Esc Anna Nery. 2013; 17(2): 328-335.
AZEVEDO ER, et al. Specific Activity Scale Improves the Detection of Symptomatic Chronic Heart Failure Patients. ABC Heart Failure & Cardiomyopathy. 2023; 3(3): 20230046.
BATTINENI G, et al. Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD). Int J Mol Sci. 2021; 22(9): 4798.
BRASIL. Ministério da Saúde (MS). Saúde do Homem. MS, 2024.
CESTARI VRF, et al. Distribuição Espacial de Mortalidade por Insuficiência Cardíaca no Brasil, 1996-2017. Arquivos Brasileiros de Cardiologia. 2022; 118(1): 41-51.
DOURADO MV, et al. Perfis clínico e epidemiológico de idosos com insuficiência cardíaca. Rev. enferm. UFPE on line. 2019; 13(2): 408-415.
GARGIULO P, et al. The metabolic syndrome in heart failure: insights to specific mechanisms. Heart Fail Rev. 2020; 25(1): 1–7.
GYALAIKORPOS I, et al. Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania. Clin Interv Aging. 2015; 10: 561–8.
HUANG ZM, et al. Prognostic Impact of Metabolic Syndrome in Patients With Heart Failure: A Meta-Analysis of Observational Studies. Front Cardiovasc Med. 2021; 8: 704446.
KHAN MS, et al. Frailty, Guideline-directed Medical Therapy, and Outcomes in Heart Failure with Reduced Ejection Fraction: GUIDE-IT Trial. JACC Heart Fail. 2022; 10(4): 266–275.
MAACK C, et al. Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology. Eur Heart J. 2018; 39(48): 4243–4254.
MADDOX TM, et al. ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. Journal of The American College of Cardiology. 2024; 83(15): 1444-1488.
MALTA DC, et al. Doenças crônicas não transmissíveis e a utilização de serviços de saúde: análise da Pesquisa Nacional de Saúde no Brasil. Rev Saúde Pública. 2017; 51(1): 1-10.
MENSAH GA. Cardiovascular Diseases in African Americans: Fostering Community Partnerships to Stem the Tide. Am J Kidney Dis. 2018; 72(5 -1): 37–42.
NOUBIAP JJ, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022; 188: 109924.
POWELL-WILEY TM, et al. Obesity and Cardiovascular Disease. Circulation. 2021; 143(21): 984–1010.
PURWOWIYOTO S, et al. Metabolic syndrome and heart failure: mechanism and management. Med Pharm Rep. 2021; 94(1): 15–21.
RODACKI M, et al. Diagnóstico do diabetes e rastreamento do diabetes tipo 2. Diretriz Oficial da Sociedade Brasileira de Diabetes, 2023.
ROHDE LEP, et al. Diretriz brasileira de insuficiência cardíaca crônica e aguda. Arq. bras. Cardiol. 2018; 111(3): 436-539.
SANTOS BS, et al. Análise clínica e epidemiológica dos casos de insuficiência cardíaca na região nordeste. Brazilian Journal of Implantology and Health Sciences. 2024; 6(1): 1650-1670.
SAVARESE G, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022; 118(17): 3272-3287.
SILVA CC, et al. Mapeamento da ocorrência da insuficiência cardíaca com síndrome metabólica em serviço ambulatorial de referência do estado de Pernambuco. Anais da XX Jornada de Iniciação Científica. Revista Eletrônica (Estácio Recife). 2022; 7(3).
SILVA JF, et al. Síndrome Metabólica em Pacientes com Insuficiência Cardíaca. Int. j. cardiovasc. sci. 2015; 28(3): 206-214.
VAN DER HOEF CCS, et al. Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. European Journal of Heart Failure. 2023; 25(2): 163-173.
WAJNER A, et al. Causas e Preditores de Mortalidade Intra-Hospitalar em Pacientes que internam com ou por Insuficiência Cardíaca em Hospital Terciário no Brasil. Arq Bras Cardiol. 2017; 321-3.
XAVIER HT, et al. V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arq. Bras. Cardiol. 2013; 101(4 -1): 1-20.
ZHOU Y, et al. Association Between Metabolic Syndrome and an Increased Risk of Hospitalization for Heart Failure in Population of HFpEF. Front Cardiovasc Med. 2021; 8: 698117.